SRL Diagnostics

Competitive pressures, valuations cap gains from current levels

Indian Olympic Association accepted SRL Diagnostics' offer to join hands as 'Lab Diagnostics Partner' to provide services to athletes and officials attending the Tokyo Olympics and 2024 Paris Games

Non-Covid revenues are back to 80% of Jan levels. Some expect demand to be 1.2 times pre-Covid level by Diwali

Anand has over 25 years of experience in the healthcare industry in India and international markets

The share of labs run by private hospitals is growing on the list of those that have permission to test reverse transcription polymerase chain reaction (RT-PCR).

Expansion, raising share of B2C network to help improve margins

Company to infuse another Rs 20 billion to acquire more of the equity

A plan of setting up 100 collection centres in 100 days is on track and there is no change in plan as result of IHH Healthcare's acquisition of majority stake in Fortis Healthcare, says SRL CEO

SRL, which draws 16% of its revenue from Fortis Healthcare, is set to gain from the merger with Manipal Hospitals

Today SRL touches the lives of over 15 million patients annually in 600 cities across 30 states in India.

SRL Diagnostics plans to set up five overseas laboratories in the next six months with special focus on the African region

The company is coming up with 150 labs in domestic market and 50 labs in international market in the next five years.

Interview with CEO, SRL Diagnostics